p53 gene therapy of human breast carcinoma: using a transferrin-modified silica nanoparticles.
about
The cholesterol metabolite 27-hydroxycholesterol regulates p53 activity and increases cell proliferation via MDM2 in breast cancer cells.Current status of gene therapy for breast cancer: progress and challenges.DNA/RNA-based formulations for treatment of breast cancer.Comparison of two silica based nonviral gene therapy vectors for breast carcinoma: evaluation of the p53 delivery system in Balb/c mice.
P2860
p53 gene therapy of human breast carcinoma: using a transferrin-modified silica nanoparticles.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
p53 gene therapy of human brea ...... modified silica nanoparticles.
@en
p53 gene therapy of human brea ...... modified silica nanoparticles.
@nl
type
label
p53 gene therapy of human brea ...... modified silica nanoparticles.
@en
p53 gene therapy of human brea ...... modified silica nanoparticles.
@nl
prefLabel
p53 gene therapy of human brea ...... modified silica nanoparticles.
@en
p53 gene therapy of human brea ...... modified silica nanoparticles.
@nl
P2860
P1433
P1476
p53 gene therapy of human brea ...... modified silica nanoparticles.
@en
P2093
Chandrababu Rejeeth
Soundrapandian Kannan
P2860
P2888
P304
P356
10.1007/S12282-014-0537-Z
P577
2014-05-04T00:00:00Z
P5875
P6179
1032508198